Cadrenal Therapeutics Inc（CVKD）價格預測CVKDCadrenal Therapeutics Inc

Alphio's CVKD stock price prediction model matches the current Cadrenal Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.00 (-4.09%). The 1-week path is $1.01 (-2.46%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Cadrenal Therapeutics Inc (CVKD) is currently trading at $1.04, which is significantly lower than its 52-week high of $13.01, indicating a potential for recovery. However, the stock has a low RSI of 43.865, suggesting it is not yet oversold, and the forward P/E ratio is at 0, indicating uncertainty in future earnings. The recent positive news about a $3 million private placement and a 25% reduction in thrombotic events from CAD-1005 are encouraging signs, but the company has a substantial year-to-date decline of 85.81% and negative net income figures, with the latest reported EPS at -1.14. Therefore, while there are some positive catalysts, the overall financial performance and significant risks suggest a hold position for now.

Cadrenal Therapeutics Inc (CVKD) last closed at $1.04, gaining +4.00%. These facts feed the 1-day and 1-week CVKD price prediction above.